A neural circuit for comorbid depressive symptoms in chronic pain
Wenjie Zhou,Yan Jin,Qian Meng,Xia Zhu,Tongjian Bai,Yanghua Tian,Yu Mao,Likui Wang,Wen Xie,Hui Zhong,Na Zhang,Min-Hua Luo,Wenjuan Tao,Haitao Wang,Jie Li,Juan Li,Ben-Sheng Qiu,Jiang-Ning Zhou,Xiangyao Li,Han Xu,Kai Wang,Xiaochu Zhang,Yong Liu,Gal Richter-Levin,Lin Xu,Zhi Zhang
DOI: https://doi.org/10.1038/s41593-019-0468-2
IF: 25
2019-08-26
Nature Neuroscience
Abstract:Comorbid depressive symptoms (CDS) in chronic pain are a common health problem, but the neural circuit mechanisms underlying these symptoms remain unclear. Here we identify a novel pathway involving 5-hydroxytryptamine (5-HT) projections from the dorsal raphe nucleus (5-HTDRN) to somatostatin (SOM)-expressing and non-SOM interneurons in the central nucleus of the amygdala (CeA). The SOMCeA neurons project directly to the lateral habenula, an area known involved in depression. Inhibition of the 5-HTDRN→SOMCeA pathway produced depression-like behavior in a male mouse model of chronic pain. Activation of this pathway using pharmacological or optogenetic approaches reduced depression-like behavior in these mice. Human functional magnetic resonance imaging data showed that compared to healthy controls, functional connectivity between the CeA-containing centromedial amygdala and the DRN was reduced in patients with CDS but not in patients in chronic pain without depression. These findings indicate that a novel 5-HTDRN→SOMCeA→lateral habenula pathway may mediate at least some aspects of CDS.
neurosciences